APELLIS PHARMACEUTICALS INC. - COMMON STOCK
18.26
03-July-25 10:45:00
15 minutes delayed
Stocks
+0.44
+2.47%
Today's range
17.73 - 18.26
ISIN
N/A
Source
NASDAQ
-
Apellis Pharmaceuticals to Host a Fireside Chat at the Jefferies London Healthcare Conference
12 Nov 2024 04:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
05 Nov 2024 04:05:00 By Nasdaq GlobeNewswire
-
26 Oct 2024 11:00:00 By Nasdaq GlobeNewswire
-
22 Oct 2024 04:00:00 By Nasdaq GlobeNewswire
-
16 Oct 2024 04:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Oct 2024 13:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
25 Sep 2024 04:00:00 By Nasdaq GlobeNewswire
-
20 Sep 2024 02:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Sep 2024 13:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
29 Aug 2024 04:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2024 04:00:01 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Aug 2024 13:05:01 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results
01 Aug 2024 04:05:00 By Nasdaq GlobeNewswire
-
18 Jul 2024 04:00:00 By Nasdaq GlobeNewswire
-
09 Jul 2024 04:00:00 By Nasdaq GlobeNewswire
-
28 Jun 2024 03:57:12 By Nasdaq GlobeNewswire
-
10 Jun 2024 04:00:00 By Nasdaq GlobeNewswire
-
05 Jun 2024 04:00:00 By Nasdaq GlobeNewswire
-
24 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
14 May 2024 05:00:00 By Nasdaq GlobeNewswire